46 related articles for article (PubMed ID: 19249500)
1. Association of visceral adipose tissue with albuminuria and interaction between visceral adiposity and diabetes on albuminuria.
Liu Y; Zhao D; Chai S; Zhang X
Acta Diabetol; 2024 Jul; 61(7):909-916. PubMed ID: 38558152
[TBL] [Abstract][Full Text] [Related]
2. Contribution of membrane raft redox signalling to visfatin-induced inflammasome activation and podocyte injury.
Koka S; Surineni S; Singh GB; Boini KM
Aging (Albany NY); 2023 Nov; 15(22):12738-12748. PubMed ID: 38032896
[TBL] [Abstract][Full Text] [Related]
3. Visfatin as a Promising Marker of Cardiometabolic Risk.
Erten M
Acta Cardiol Sin; 2021 Sep; 37(5):464-472. PubMed ID: 34584379
[TBL] [Abstract][Full Text] [Related]
4. NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.
Audrito V; Messana VG; Deaglio S
Front Oncol; 2020; 10():358. PubMed ID: 32266141
[TBL] [Abstract][Full Text] [Related]
5. Adipocytokines in renal transplant recipients.
Nagy K; Nagaraju SP; Rhee CM; Mathe Z; Molnar MZ
Clin Kidney J; 2016 Jun; 9(3):359-73. PubMed ID: 27274819
[TBL] [Abstract][Full Text] [Related]
6. Association between serum visfatin and carotid atherosclerosis in diabetic and non-diabetic patients on maintenance hemodialysis.
El-Shishtawy SH; Mosbah O; Sherif N; Metwaly A; Hanafy A; Kamel L
Electron Physician; 2016 Feb; 8(2):1966-72. PubMed ID: 27054006
[TBL] [Abstract][Full Text] [Related]
7. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.
Manna P; Jain SK
Metab Syndr Relat Disord; 2015 Dec; 13(10):423-44. PubMed ID: 26569333
[TBL] [Abstract][Full Text] [Related]
8. Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.
Hsu CY; Huang PH; Chen TH; Chiang CH; Leu HB; Huang CC; Chen JW; Lin SJ
Am J Hypertens; 2016 Apr; 29(4):528-36. PubMed ID: 26298010
[TBL] [Abstract][Full Text] [Related]
9. Obesity in kidney disease: A heavyweight opponent.
Felizardo RJ; da Silva MB; Aguiar CF; Câmara NO
World J Nephrol; 2014 Aug; 3(3):50-63. PubMed ID: 25332896
[TBL] [Abstract][Full Text] [Related]
10. Visfatin/Nampt: an adipokine with cardiovascular impact.
Romacho T; Sánchez-Ferrer CF; Peiró C
Mediators Inflamm; 2013; 2013():946427. PubMed ID: 23843684
[TBL] [Abstract][Full Text] [Related]
11. Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyltransferase activity.
Vallejo S; Romacho T; Angulo J; Villalobos LA; Cercas E; Leivas A; Bermejo E; Carraro R; Sánchez-Ferrer CF; Peiró C
PLoS One; 2011; 6(11):e27299. PubMed ID: 22073309
[TBL] [Abstract][Full Text] [Related]
12. Visfatin and endothelial function in dialyzed patients.
Malyszko J; Malyszko JS; Mysliwiec M
Nephrology (Carlton); 2010 Mar; 15(2):190-6. PubMed ID: 20470278
[TBL] [Abstract][Full Text] [Related]
13. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
14. Adipocytokines - novel link between inflammation and vascular function?
Guzik TJ; Mangalat D; Korbut R
J Physiol Pharmacol; 2006 Dec; 57(4):505-28. PubMed ID: 17229978
[TBL] [Abstract][Full Text] [Related]
15. Visfatin and its role in obesity development.
Stastny J; Bienertova-Vasku J; Vasku A
Diabetes Metab Syndr; 2012; 6(2):120-4. PubMed ID: 23153983
[TBL] [Abstract][Full Text] [Related]
16. Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009; 41(1):150-3. PubMed ID: 19249500
[TBL] [Abstract][Full Text] [Related]
17. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
